期刊文献+

E试验测定78株念珠菌属真菌对4种抗真菌药物的敏感性

Susceptibility of 78 Candida strains to 4 antifungal agents tested by E test
下载PDF
导出
摘要 目的检测4种抗真菌药物对念珠菌属真菌的最低抑菌浓度(MIC)并分析其耐药性。方法用E试验检测两性霉素B(AP)、酮康唑(KE)、氟康唑(FL)、伊曲康唑(IT)对78株临床分离的念珠菌属真菌的MIC值。结果78株念珠菌属真菌对AP、KE、FL、IT的总敏感率分别是89.7%、92.3%、85.9%、85.9%;白念珠菌对AP、KE、FL和IT的敏感率分别是96.9%、96.9%、100%和87.5%。结论4种药物对白念珠菌的体外抗菌活性均较好,但对非白念珠菌的抗菌活性则较前者为差。 Objective This study was designed to determine MICs of 4 antifungal agents against Candida isolates and evaluate drug resistance in Candida spp. Methods MICs of amphotericin B (AP), ketoconazole (KE), fluconazole (FL), itraconazole (IT) were determined on 78 clinical isolates of Candida by E test. Results The susceptibility rate of 78 strains of Candida to AP, KE, FL, IT was 89.7 %, 92.3 %, 85.9 % and 85.9 % respectively. The susceptibility rate of Candida albicans to the above 4 antifungal agents was 96.9%, 96.9%, 100% and 87. 5% accordingly. Conclusions The 4 antifungal agents tested have good antifungal activity against Candida albicans in vitro. Their antifungal activity against other Candida spp. is not as good as against Candida albicans.
出处 《中国抗感染化疗杂志》 CAS 2005年第4期229-230,共2页 Chinese Journal of Infection and Chemotherapy
关键词 E试验 念珠菌属真菌 耐药性 E test Candida Resistance
  • 相关文献

参考文献5

二级参考文献44

  • 1周贵民,谢灵.ATBFUNGUS在酵母菌药敏测定中的应用及其临床意义[J].中华医学检验杂志,1994,17(2):99-101. 被引量:18
  • 2张正,赵素蕊,庞良锦,王贺,刘文芸,严薇.临床标本分离475株酵母样真菌调查分析[J].中华医学检验杂志,1996,19(5):267-269. 被引量:40
  • 3周贵民,谢灵.国内酵母菌感染和实验室诊断的现状及建议[J].中华医学检验杂志,1996,19(5):301-303. 被引量:83
  • 4王端礼.要重视真菌检验工作[J].中华医学检验杂志,1996,19(5):263-263.
  • 5Pfaller MA, Diekema DJ, Jones RN,et al. Trends in antifungal susceptibility of Candida spp isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000[J]. J Clin Microbiol, 2002,40(3): 852-856.
  • 6Doczi I, Dosa E, Hajdu E,et al. Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000[J]. J Med Microbiol, 2002,51 : 677-681.
  • 7Verweli PE, Erjaver Z, Sluiters W, etal. Detection of antigen in sera of patients with invasive aspergillosis[J]. J Clin Microbiol, 1998,36 (6) :1612-1616.
  • 8Gharnoum MA, Rex JH, Galgian JN. Susceptibility testing of fungi. Current status of correlation of in vitro data with clinical outcome[J]. J Clin Microbiol, 1996, 34(3):489-495.
  • 9Pfaller MA, Jones RN, Doern GV, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY program[J]. J Clin Microbiol, 1998,36(7) : 1886-1889.
  • 10Marco F, Pfaller MA, Messer S, et al. In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp [J]. Antimicrob Agents Chemother, 1998,42(1) : 161-163.

共引文献173

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部